Literature DB >> 34669529

Smoking tobacco is associated with renal hyperfiltration.

Malin Mickelsson1, Elisabet Söderström2, Kristina Stefansson1, Jonas Andersson3, Stefan Söderberg4, Johan Hultdin1.   

Abstract

Tobacco consumption is a renal risk factor, but the effects on the estimated glomerular filtration rate (eGFR) remain unclear. We aimed to evaluate the possible impact of using tobacco products (smoking and snus) on eGFR based on creatinine or cystatin C. We used a first cohort with 949 participants and a second cohort with 995 participants; none had pre-existing renal disease. All subjects donated a blood sample and completed a questionnaire, including questions about tobacco use. To assess the effect on eGFR, hierarchical multiple linear regression models were used. Active smoking associated independently with a higher eGFRcreatinine in all subjects (p < 0.001; β = 0.11). Further analyses stratified for sex, showed similar findings for men (p < 0.001; β = 0.14) and for women (p = 0.026; β = 0.10). eGFRcystatin C was significantly associated with active smoking in all subjects (p = 0.040; β = -0.05), but no association was seen after stratification for sex. Snus did not associate with eGFR. In conclusion, smoking associated significantly with a higher eGFRcreatinine. The mechanism may be renal hyperfiltration of smaller molecules such as creatinine. This is probably caused by substances from smoked tobacco other than nicotine, as no effect was seen for snus.

Entities:  

Keywords:  Tobacco; creatinine; cystatin C; glomerular filtration rate; smokeless; smoking; tobacco,

Mesh:

Substances:

Year:  2021        PMID: 34669529     DOI: 10.1080/00365513.2021.1989713

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  1 in total

1.  Pulse pressure and the risk of renal hyperfiltration in young adults: Results from Korea National Health and Nutrition Examination Survey (2010-2019).

Authors:  Eunji Yang; Sang Ho Park; Seoyoung Lee; Donghwan Oh; Hoon Young Choi; Hyeong Cheon Park; Jong Hyun Jhee
Journal:  Front Med (Lausanne)       Date:  2022-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.